3.2 Multimorbidity & Chronic Disease Interactions

3.2 Multimorbidity & Chronic Disease Interactions

Multimorbidity means two or more chronic conditions. Competing prescriptions can burden intake in an older adult, especially with frailty or limited resources. Assess which clinical goals have current benefit and prioritize an individualized plan that preserves nutrition, function, symptoms, and preferences.

Reconstruct Medical and Treatment History

Review the patient interview, previous admissions, discharge summary, current diagnoses, operations, treatment orders, and observations from nursing and rehabilitation. Establish the sequence: did poor intake precede illness, start with a medicine or procedure, or emerge after transfer? Record pre-illness function, weight, intake, and the source and reliability of each datum. Conflicting chart weights require verification rather than averaging incompatible measurements.

Treatment history can explain nutritional effects. Ask about GI resections or bariatric surgery, radiation involving the mouth or GI tract, chemotherapy-related nausea, dialysis losses, recurrent infection, and courses of antibiotics. Investigate vomiting, diarrhea, constipation, early satiety, dental pain, and new swallowing problems. A previous disease label does not explain every current symptom, and supplements do not replace assessment of possible bleeding, obstruction, or acute illness.

For example, a patient with stable COPD eats poorly after hip repair. Compare pain, opioid use, bowel movements, nausea, assistance, and rehabilitation fatigue with the preoperative routine before attributing all weight loss to pulmonary cachexia. Identify actionable barriers and communicate urgent medical findings to the treating team. Use this history to prioritize interventions and select monitoring indicators.

Heart Failure, Sodium Restrictions & Cardiac Cachexia

Heart failure (HF) affects approximately 10% of older adults aged 80 and older and represents the leading cause of hospitalization in Medicare beneficiaries. Effective nutritional management balances sodium and fluid equilibrium without compromising overall energy intake.

Sodium and Fluid Goals Without Compromising Intake

The AHA/ACC/HFSA heart-failure guideline recommends avoiding excessive sodium to reduce congestive symptoms; it does not establish one proven 2,000–2,400 mg target for every patient. An unpalatable restriction may worsen intake, but a regular or no-added-salt diet is not automatically appropriate for all patients with heart failure. Review congestion, medications, blood pressure, kidney function, intake, and preferences with the medical team. No-added-salt describes a menu practice, not a fixed sodium content.

Rising creatinine and orthostasis warrant assessment for dehydration, medication effects, and other causes. They do not establish prerenal azotemia solely from the absence of peripheral edema. Liberalization should be individualized and monitored for both intake and congestive symptoms.

Cardiac Cachexia Pathophysiology

Cardiac cachexia involves disease-associated, non-edematous wasting that is not fully reversed by conventional feeding alone. Assess serial euvolemic weights, muscle loss, intake, symptoms, and inflammation rather than treating one weight-loss interval as a complete diagnosis:

• Neurohormonal Activation: Overactivation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) drives resting energy expenditure into hypermetabolic states.
• Pro-inflammatory Cytokine Surge: Elevated circulating concentrations of tumor necrosis factor-alpha ($\text{TNF-}\alpha$, historically known as cachectin), interleukin-1 beta ($\text{IL-}1\beta$), and interleukin-6 ($\text{IL-}6$) stimulate ubiquitin-proteasome muscle proteolysis, suppress hepatic albumin synthesis, and induce profound central anorexia.
• Gastrointestinal Malabsorption: Elevated central venous pressure produces chronic bowel wall edema, blunting intestinal villi, impairing nutrient absorption, and causing protein-losing enteropathy and early satiety.

Fluid Management & Weight Monitoring

In ambulatory, compensated heart failure, routine fluid restriction is rarely required. In decompensated HF (NYHA Class IV) or severe hypervolemic hyponatremia (serum sodium $<130\text{ mEq/L}$), the medical team may consider an individualized fluid restriction of $1.5\text{--}2.0\text{ L/day}$.

Daily weight monitoring is the most sensitive metric for detecting subclinical fluid accumulation:

• Weigh the patient daily in the morning, immediately following first void, prior to breakfast, using the same calibrated scale and comparable clothing.
• Clinical Action Triggers: A rapid weight gain of $\ge 2\text{--}3\text{ lb}$ in 24 hours or $\ge 5\text{ lb}$ in one week indicates pathological fluid retention rather than true tissue accretion, requiring contact with the treating team and evaluation under the patient’s action plan.

Chronic Kidney Disease (CKD) & The Geriatric Protein Dilemma

CKD requires kidney structural or functional abnormality persisting at least three months. Stage using eGFR and markers such as urine ACR, interpreted with muscle mass and clinical context. Low eGFR should not be dismissed as normal aging, while low creatinine with sarcopenia may overestimate filtration.

The Geriatric Protein Dilemma

KDIGO 2024 suggests maintaining approximately 0.8 g/kg/day of protein in adults with CKD G3–G5 and avoiding high intake above 1.3 g/kg/day in people at risk of progression. Selected lower-protein regimens require close supervision and should not be prescribed to metabolically unstable patients. These are not blanket instructions to feed every older adult 0.6 g/kg/day.

KDIGO explicitly advises considering higher protein and calorie targets in older adults with frailty or sarcopenia. Balance kidney preservation against malnutrition, function, prognosis, and preferences. A case target such as 0.8–1.0 g/kg/day may be reasonable with the treating team, but it is not a universal frailty prescription. Monitor intake, weight, strength, uremic symptoms, electrolytes, and kidney function.

For metabolically stable adults on maintenance hemodialysis or peritoneal dialysis, KDOQI 2020 uses 1.0–1.2 g/kg/day as a starting protein recommendation. Individual needs may be higher with illness or losses. Dialysis status, energy adequacy, and clinical response determine the final plan.

Mineral & Acid-Base Balance

• Potassium: Individualize intake with the kidney-care team according to hyperkalemia, medications, acid-base status, food sources, and clinical risk. Do not use a universal 2,000–3,000-mg restriction or eliminate produce automatically.
• Phosphorus: Limit inorganic phosphate food additives (e.g., phosphoric acid, sodium polyphosphate in processed meats and colas), which have a 90% to 100% intestinal absorption rate, whereas organic plant-based phytate phosphorus is only 20% to 40% bioavailable. Prescribe phosphate binders to be taken strictly with meals.
• Metabolic Acidosis: Low bicarbonate can contribute to muscle and bone problems. KDIGO 2024 advises considering treatment when acidosis has potential clinical consequences, giving bicarbonate below 18 mmol/L as an example; treatment and sodium load require medical review.

Type 2 Diabetes Mellitus: Relaxed Targets & Hypoglycemia Avoidance

Diabetes affects over 25% of individuals aged $\ge 65$. The core objective of geriatric diabetes care is the prevention of acute hypoglycemia rather than the aggressive prevention of distant microvascular complications.

Relaxed Glycemic Targets

Benefit and risk depend on health, treatment, and prognosis. Healthy older adults can benefit from appropriate glycemic management, while hypoglycemia-causing regimens may be harmful in frailty. Both the American Diabetes Association (ADA) and the American Geriatrics Society (AGS) endorse stratified Glycated Hemoglobin ($\text{HbA}_{1c}$) targets:

• Healthy Older Adults (Few co-existing chronic conditions, intact cognition, long life expectancy): $\text{HbA}_{1c} < 7.0\text{--}7.5$%
• Complex Health (Multiple chronic conditions, mild-to-moderate cognitive impairment, 2+ IADL dependencies): $\text{HbA}_{1c} < 8.0$%
• Very Complex/Poor Health: Avoid reliance on HbA1c; prioritize avoiding hypoglycemia and symptomatic hyperglycemia.

Hypoglycemia: The Primary Clinical Hazard

Age-related autonomic neuropathy blunts sympathoadrenal counterregulatory responses, resulting in hypoglycemia unawareness. Older adults frequently fail to manifest classic adrenergic warning symptoms (tremors, diaphoresis, palpitations). Instead, hypoglycemia manifests as neuroglycopenic dysfunction: acute delirium, dizziness, falls, traumatic hip fractures, transient ischemic symptoms, ventricular arrhythmias, and myocardial infarction. Recurrent hypoglycemia accelerates vascular dementia and cognitive decline.

Nutrition Interventions: Eliminating Restrictive Sugar Bans

In long-term care facilities, restrictive "No Concentrated Sweets" (NCS) or "No Added Sugar" (NAS) meal plans should be abandoned:

• Rigid sugar bans cause unpalatable meals, depression, and severe unintended weight loss.
• The evidence-based standard is Consistent Carbohydrate Distribution: distributing balanced quantities of complex carbohydrates evenly across three meals and snacks to stabilize postprandial glucose excursions while honoring resident food autonomy.

Chronic Obstructive Pulmonary Disease (COPD) & Pulmonary Cachexia

COPD is characterized by persistent respiratory symptoms and airflow limitation. Some patients develop disease-associated wasting or low fat-free mass, including at a normal or elevated BMI. Low muscle mass alone does not establish cachexia.

Pathophysiological Drivers

• Work of Breathing: Respiratory work and systemic illness may raise needs, but expenditure varies. Estimate requirements and monitor weight and intake instead of adding a fixed 430–720 kcal/day to every prescription.
• Early Satiety & Aerophagia: Hyperinflated lungs flatten the diaphragm, which physically compresses the gastric fundus, producing early fullness after only several bites. Chronic dyspnea and mouth breathing promote aerophagia, causing bloating and abdominal discomfort.

Medical Nutrition Therapy in COPD

• High-energy, high-protein meal plans distributed into 5 to 6 small, nutrient-dense meals per day.
• Rest for 30 minutes before dining; coordinate prescribed respiratory treatment and meal timing with the treating team.
• Serve soft, easy-to-chew foods to minimize chewing fatigue; drink liquids between meals rather than with meals to prevent early gastric distension.

Neurological Disorders: Stroke & Parkinson's Disease

Neurological conditions alter neuromuscular coordination, dining independence, and metabolic regulation.

Stroke (Cerebrovascular Accident / CVA)

• Post-Stroke Dysphagia: Affects 40% to 70% of acute stroke survivors, placing them at profound risk for silent aspiration, aspiration pneumonia, dehydration, and asphyxiation. A trained healthcare professional should perform a validated swallow screen before oral intake, with SLP assessment when indicated.
• Functional Deficits: Unilateral hemiparesis requires occupational therapy evaluation for adaptive tableware (such as weighted utensils, rocker knives, and plate guards). Homonymous hemianopia (loss of half the visual field) requires nursing and dining staff to orient food trays within the intact visual field and instruct the resident to scan the plate.

Parkinson's Disease (PD)

• Motor Symptoms: Resting tremors, rigidity, and bradykinesia impair self-feeding mechanics and increase caloric requirements.
• Autonomic Dysmotility: Lewy body pathology infiltrates the enteric nervous system, causing severe gastroparesis (delayed gastric emptying) and chronic colonic dysmotility. Gastroparesis causes persistent nausea, early satiety, and erratic absorption of oral medications. Pharyngeal muscle rigidity causes progressive dysphagia, requiring texture-modified diets.

Primary source check

KDIGO 2024 CKD guideline, checked October 13, 2026.

AHA/ACC/HFSA heart-failure guideline, checked October 13, 2026.